Abstract
More than 30% of all human cancers contain activating mutations of the small G-protein RAS. As a result of this, RAS has been intensely studied and many efforts have been made to identify pathways that sustain RAS-driven transformation. Recent studies have indicated that the transcription factor GATA2 is one of these partners in crime, but a mechanistic link between RAS and GATA2 had not been identified. A paper in this issue of EMBO reports closes this gap showing that GATA2 can be activated by p38 in RAS-transformed cells [3]..
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 912-913 |
Seitenumfang | 2 |
Fachzeitschrift | EMBO Reports |
Jahrgang | 15 |
Ausgabenummer | 9 |
DOIs | |
Publikationsstatus | Veröffentlicht - Sept. 2014 |
ÖFOS 2012
- 106013 Genetik